Although the median proliferation index in NEC (80% in one recent series) exceeds that in G3 NET (50% in the same series), the ranges are overlapping such that Ki-67 should not be used alone in the distinction of these two tumor types (Tang et al. 2016a). This evidence concerns the gene MKI67 and neuroendocrine carcinoma.